Results 91 to 100 of about 1,293 (173)

Alpelisib and Fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the German PRAEGNANT trial. [PDF]

Breast Cancer Res Treat
Hörner M, Tretschock LM, John N, Ziegler P, Häberle L, Uhrig S, Goossens C, Amann N, Cieslik JP, Dannehl D, Deutsch TM, Dimpfl M, Ehlert M, Eichstädt K, Englisch A, Köpke MB, Krückel A, Link T, Müller A, Reinhardt K, Roth J, Schäffler H, Sych L, Tegeler CM, Wichmann C, Banys-Paluchowski M, Princk H, Rody A, Brucker SY, Ditsch N, Ettl J, Fehm T, Hack CC, Hadji P, Hein A, Janni WW, Kolberg HC, Lüftner D, Lux MP, Müller V, Schneeweiss A, Taran FA, Tesch H, Wallwiener D, Marmé F, Seitz S, Belleville E, Hartkopf A, Michel LL, Wallwiener M, Fasching PA, Tauber N.   +51 more
europepmc   +1 more source

Mehrsprachigkeit, Englisch und Literatur(unterricht)

Zeitschrift für Interkulturellen Fremdsprachenunterricht, 2014
Werner Delanoy
doaj   +1 more source

[Implementation research-effective implementation of evidence-based interventions into practice]. [PDF]

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
El Bcheraoui C, Hanefeld J, Schaade L.
europepmc   +1 more source

Dipeptidic Phosphonates: Potent Inhibitors of Pseudomonas aeruginosa Elastase B Showing Efficacy in a Murine Keratitis Model. [PDF]

Adv Sci (Weinh)
Kiefer AF, Schütz C, Englisch CN, Kolling D, Speicher S, Kany AM, Shafiei R, Wadood NA, Aljohmani A, Wirschem N, Jumde RP, Klein A, Sikandar A, Park YM, Krasteva-Christ G, Yildiz D, Abdelsamie AS, Rox K, Köhnke J, Müller R, Bischoff M, Haupenthal J, Hirsch AKH.   +22 more
europepmc   +1 more source

Conjunctival melanoma with pronounced central corneal invasion: One-year relapse free follow-up. [PDF]

Am J Ophthalmol Case Rep
Englisch CN, Berger T, Flockerzi F, Bofferding M, Seitz B.   +4 more
europepmc   +1 more source

Anticoagulation Quality Improvement Project: Reducing Noncompliant Anticoagulation Administrations in Patients With Cancer and Thrombocytopenia. [PDF]

Clin J Oncol Nurs
Toale KM, Scanlan R, Mathew JA, Lopez KL, Esmaily-Fard A, Richardson GB.   +5 more
europepmc   +1 more source

PARP inhibition with olaparib and talazoparib for HER2-negative advanced breast cancer-Results from the prospective PRAEGNANT registry. [PDF]

NPJ Breast Cancer
Hörner M, Hartkopf A, John N, Ziegler P, Häberle L, Uhrig S, Goossens C, Amann N, Cieslik JP, Tretschock LM, Dannehl D, Deutsch TM, Dimpfl M, Ehlert M, Eichstädt K, Englisch A, Köpke MB, Krückel A, Link T, Müller A, Reinhardt K, Roth J, Schäffler H, Sych L, Tauber N, Tegeler CM, Wichmann C, Banys-Paluchowski M, Princk H, Rody A, Brucker SY, Ditsch N, Ettl J, Fehm T, Hack CC, Hadji P, Hein A, Janni WW, Kolberg HC, Lüftner D, Lux MP, Müller V, Taran FA, Tesch H, Wallwiener D, Marmé F, Seitz S, Belleville E, Michel LL, Wallwiener M, Fasching PA, Schneeweiss A, Maurer C.   +52 more
europepmc   +1 more source

The Impact of Adjunctive Aripiprazole on Olanzapine-Induced Metabolic Adverse Effects in Patients With Schizophrenia: A Systematic Review. [PDF]

Neuropsychopharmacol Rep
Simmons S, Sadiq S.
europepmc   +1 more source

Long-term astigmatism after intraocular pressure sensor implantation and nonpenetrating glaucoma surgery: EYEMATE-SC trial. [PDF]

J Cataract Refract Surg
Englisch CN, Boden KT, Szurman P, Mansouri K, Dick HB, Hoffmann EM, Mackert MJ, Schütte P, Langenbucher A, Messias A, Wakili P.   +10 more
europepmc   +1 more source

Association of clonal haematopoiesis with recurrent venous thromboembolism: A case-control study. [PDF]

Br J Haematol
Englisch C, Vostatek R, Schramm T, Binder CJ, Pabinger I, Jäger R, Ay C.   +6 more
europepmc   +1 more source